AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.92
+0.14
(+1.05%)
Pre-Market: 08:01
AbCellera Biologics Profit Margin (Quarterly) : -1.37K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.37K% |
| March 31, 2026 | -519.1% |
| December 31, 2025 | -19.94% |
| September 30, 2025 | -637.8% |
| June 30, 2025 | -203.3% |
| March 31, 2025 | -1.08K% |
| December 31, 2024 | -677.4% |
| September 30, 2024 | -785.4% |
| June 30, 2024 | -504.3% |
| March 31, 2024 | -408.0% |
| December 31, 2023 | -513.7% |
| September 30, 2023 | -433.6% |
| June 30, 2023 | -303.6% |
| Date | Value |
|---|---|
| March 31, 2023 | -329.0% |
| December 31, 2022 | -138.7% |
| September 30, 2022 | 26.26% |
| June 30, 2022 | -14.78% |
| March 31, 2022 | 53.25% |
| December 31, 2021 | 43.03% |
| September 30, 2021 | -388.2% |
| June 30, 2021 | -8.40% |
| March 31, 2021 | 57.82% |
| December 31, 2020 | 56.27% |
| September 30, 2020 | -28.75% |
| June 30, 2020 | 29.02% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| MindWalk Holdings Corp. | -158.7% |
| Repligen Corp. | 2.45% |
| Bio-Techne Corp. | 17.01% |
| Aurinia Pharmaceuticals, Inc. | 44.96% |
| BioLife Solutions, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -17.25% |
| Return on Assets | -12.23% |
| Return on Invested Capital | -15.04% |
| Gross Profit Margin (Quarterly) | -116.9% |
| Operating Margin (Quarterly) | -1.55K% |
| Return on Net Operating Assets | -29.68% |